Anti-Apoptosis Effects on Hearts of SHSST Cyclodextrin Complex in a Carbon Tetrachloride-Induced Cirrhotic Cardiomyopathy Rat Model

10.4077/CJP.2015.BAD286

Cheng-Hsun Yang；Wei-Jen Ting；Pei-Ying Pai；Sheng-Huang Chang；Tsung-Jung Ho；Jing-Ying Lin；Fuu-Jen Tsai；Viswanadha Vijaya Padama；Yuhsin Tsai；Chih-Yang Huang

baicalein ； beta-cyclodextrin modified SHSST ； cirrhotic cardiomyopathy ； silymarin

The Chinese Journal of Physiology

58卷1期（2015 / 02 / 01）

38 - 45

英文

Cirrhotic cardiomyopathy (CCM) is a common cardiac dysfunction in patients waiting for orthotopic liver transplantation (OLT). Carbon tetrachloride (CCl_4) intraperitoneal (IP) injection has been reported as successful in a cirrhosis-induced CCM model. In this work, we used the same assay for CCM induction using CCl_4 (0.2mg/kg) IP injection twice per day for 14 days during the cardiac protection drugs treatment process. The cardiac protection drugs were silymarin (100mg/kg/day), baicalein (30mg/kg/day), San Huang Shel Shin Tang (SHSST, 30mg/kg/day) and β-cyclodextrin modified SHSST (SHSSTc, 30mg/kg/day and 300mg/kg/day). After 4 weeks of treatment, the SHSSTc cardiac protection effects were determined through activation of the IGF1R cell survival pathway and inhibition of Fas-FADD death domain induced-apoptosis. SHSSTc cardiac protection was enhanced through β-cyclodextrin modification, which increased bio-availability, and displayed stronger protective effects than silymarin and baicalein, both of which are well-known liver protection drugs. Thus, SHSSTc might provide the best therapeutic benefit in CCM treatment.

1. Lin, T.H.,Chen, W.C.,Wu, H.C.,Chien, W.S.,Lee, S.S.,Tsai, F.J.,Tsai, C.H.,Ting, W.J.,Kuo, S.C.,Huang, C.Y.(2014).Induction of apoptosis in human DU145 prostate cancer cells by KHC-4 treatment.Chinese J. Physiol,57,99-104.
   連結：
2. Liu, H.,Sun, H.,Liu, C.(2011).Interference of the apoptotic signaling pathway in RGC stress response by SP600125 in moderate ocular hypertensive rats..Chinese J. Physiol,54,124-132.
   連結：
3. Attama, A.A.,Nzekwe, I.T.,Nnamani, P.O.,Adikwu, M.U.,Onugu, C.O.(2003).The use of solid self-emulsifying systems in the delivery of diclofenac.Int. J. Pharm,262,23-28.
4. Baik, S.K.,Fouad, T.R.,Lee, S.S.(2007).Cirrhotic cardiomyopathy.Orphanet. J. Rare Dis,2,15.
5. Chien, C.F.,Wu, Y.T.,Tsai, T.H.(2011).Biological analysis of herbal medicines used for the treatment of liver diseases.Biomed. Chromatogr,25,21-38.
6. El-Shitany, N.A.,El-Haggar, S.,El-desoky, K.(2008).Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.Food Chem. Toxicol,46,2422-2428.
7. Enache, I.,Oswald-Mammosser, M.,Woehl-Jaegle, M.L.,Habersetzer, F.,Di Marco, P.,Charloux, A.,Doutreleau, S.(2013).Cirrhotic cardiomyopathy and hepatopulmonary syndrome: prevalence and prognosis in a series of patients.Respir. Med,107,1030-1036.
8. Fang, F.,Wang, J.B.,Zhao, Y.L.,Jin, C.,Kong, W.J., Zhao, H.P., Wang, H.J.,Xiao, X.H.(2011).A comparative study on the tissue distributions of rhubarb anthraquinones in normal and CCl4- injured rats orally administered rhubarb extract..J. Ethnopharmacol,137,1492-1497.
9. Gadad, P.C.,Matthews, K.H.,Knott, R.M.(2013).Silymarin released from sterile wafers restores glucose impaired endothelial cell migration.Int. J. Pharm,457,40-49.
10. Grunert, M.,Gottschalk, K.,Kapahnke, J.,Gündisch, S.,Kieser, A.,Jeremias, I.(2012).The adaptor protein FADD and the initiator caspase-8 mediate activation of NF-κB by TRAIL..Cell Death Dis.,3,e414.
11. Hammam, O.,Mahmoud, O.,Zahran, M.,Aly, S.,Hosny, K.,Helmy, A.,Anas, A.(2012).The role of Fas/Fas ligand system in the pathogenesis of liver cirrhosis and hepatocellular carcinoma.Hepat. Mon.,12,e6132.
12. Horova, V.,Hradilova, N.,Jelinkova, I.,Koc, M.,Svadlenka, J.,Brazina, J.,Klima, M.,Slavik, J.,Hyrslova Vaculova, A.,Andera, L.(2013).Inhibition of vacuolar ATPase attenuates the TRAILinduced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.FEBS J.,280,3436-3450.
13. Hsu, C.M.,Yu, S.C.,Tsai, F.J.,Tsai, Y.(2013).Enhancement of rhubarb extract solubility and bioactivity by 2-hydroxypropyl-β-cyclodextrin..Carbohydr. Polym,98,1422-1429.
14. Hsu, S.C.,Lin, J.H.,Weng, S.W.,Chueh, F.S.,Yu, C.C.,Lu, K.W.,Wood, W.G.,Chung, J.G.(2013).Crude extract of Rheum palmatum inhibits migration and invasion of U-2 OS human osteosarcoma cells by suppression of matrix metalloproteinase-2 and -9..BioMedicine,3,120-129.
15. Huang, C.Y.,Lee, S.D.(2012).Possible pathophysiology of heart failure in obesity: cardiac apoptosis..BioMedicine,2,36-40.
16. Lee, S.D.,Shyu, W.C.,Cheng, I.S.,Kuo, C.H.,Chan, Y.S.,Lin, Y.M.,Tasi, C.Y.,Tsai, C.H.,Ho, T.J.,Huang, C.Y.(2013).Effects of exercise training on cardiac apoptosis in obese rats.Nutr. Metab Cardiovasc. Dis.,23,566-573.
17. Liu, L.,Chen, Z.(2012).Analysis of four alkaloids of Coptis chinensis in rat plasma by high performance liquid chromatography with electrochemical detection.Anal. Chim. Acta,737,99-104.
18. Mandegary, A.,Saeedi, A.,Eftekhari, A.,Montazeri, V.,Sharif, E.(2013).Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism.Daru,2,28.
19. Møller, S.,Henriksen, J.H.(2010).Cirrhotic cardiomyopathy.J. Hepatol.,53,179-190.
20. Møller, S.,Hove, J.,Dixen, U.,Bendtsen, F.(2013).New insights into cirrhotic cardiomyopathy.Int. J. Cardiol,167,1101-1108.
21. Nan, J.X.,Park, E.J.,Kim, Y.C.,Ko, G.,Sohn, D.H.(2002).Scutellaria baicalensis inhibits liver fibrosis induced by bile duct ligation or carbon tetrachloride in rats.J. Pharm. Pharmacol,54,555-563.
22. Papastergiou, V.,Skorda, L.,Lisgos, P.,Papakonstantinou, N.,Giakoumakis, T.,Ntousikos, K.,Karatapanis, S.(2012).Ultrasonographic prevalence and factors predicting left ventricular diastolic dysfunction in patients with liver cirrhosis: is there a correlation between the grade of diastolic dysfunction and the grade of liver disease?.Sci. World J.,2012,615057.
23. Pferschy-Wenzig, E.M.,Atanasov, A.G.,Malainer, C.,Noha, S.M.,Kunert, O.,Schuster, D.,Heiss, E.H.,Oberlies, N.H.,Wagner, H.,Bauer, R.,Dirsch, V.M.(2014).Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gamma..J. Nat. Prod.,77,842-847.
24. Pozzi, M.,Grassi, G.,Ratti, L.,Favini, G.,Dell'Oro, R.,Redaelli, E.,Calchera, I.,Boari, G.,Mancia, G.(2005).Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis.Am. J. Gastroenterol,100,1110-1116.
25. Sakamaki, J.,Daitoku, H.,Ueno, K.,Hagiwara, A.,Yamagata, K.,Fukamizu, A.(2011).Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.Proc. Natl. Acad. Sci. USA,108,6085-6090.
26. Shin, J.N.,Han, J.H.,Kim, J.Y.,Moon, A.R.,Kim, J.E.,Chang, J.H.,Bae, J.,Oh, J.W.,Kim, T.H.(2013).MUDENG is cleaved by caspase-3 during TRAIL-induced cell death..Biochem. Biophys. Res. Commun,435,234-238.
27. Snipelisky, D.,Donovan, S.,Levy, M.,Satyanarayana, R.,Shapiro, B.(2013).Cardiac troponin elevation predicts mortality in patients undergoing orthotopic liver transplantation..J. Transplant.,2013,252838.
28. Timoh, T.,Protano, M.A.,Wagman, G.,Bloom, M.,Vittorio, T.J.(2011).A perspective on cirrhotic cardiomyopathy.Transplant. Proc.,43,1649-1653.
29. Tsai, Y.S.,Tsai, H.H.,Wu, C.P. ,Tsai, F.J.(2010).Preparation, characterization and activity of the inclusion complex of paeonol with p-cyclodextrin.Food Chem,120,837-841.
30. Vyas, A.,Saraf, S.,Saraf, S.(2008).Cyclodextrin based novel drug delivery systems..J. Incl. Phenom. Macrocycl. Chem.,62,23-42.
31. Wang, C.Z.,Calway, T.D.,Wen, X.D.,Smith, J.,Yu, C.,Wang, Y.,Mehendale, S.R.,Yuan, C.S.(2013).Hydrophobic flavonoids from Scutellaria baicalensis induce colorectal cancer cell apoptosis through a mitochondrial-mediated pathway.Int. J. Oncol.,4,1018-1026.
32. Wang, J.B.,Zhao, H.P.,Zhao, Y.L.,Jin, C.,Liu, D.J.,Kong, W.J.,Fang, F.,Zhang, L.,Wang, H.J.,Xiao, X.H.(2011).Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury..PLoS One,6,e24498.
33. Wong, F.(2009).Cirrhotic cardiomyopathy.Hepatol. Int.,3,294-304.
34. Xu, Z.D.,Xu, H.T.,Li, W.W.,Zou, Z.,Shi, X.Y.(2013).Influence of preoperative diastolic dysfunction on hemodynamics and outcomes of patients undergoing orthotopic liver transplantation.Int. J. Clin Exp. Med,6,351-357.
35. Yang, C.H.,Ting, W.J.,Day, C.H.,Ju, D.T.,Yeh, Y.L.,Chung, L.C.,Tsai, F.J.,Tsai, C.H.,Tsai, Y.,Huang, C.Y.(2014).SHSST cyclodextrin complex prevents the fibrosis effect on CCl4-induced cirrhotic cardiomyopathy in rats through TGF-β pathway inhibition effects.Int. J. Mol. Sci.,15,8037-8048.
36. Ye, X.,Feng, Y.,Tong, Y.,Ng, K.M.,Tsao, S.,Lau, G.K.,Sze, C.,Zhang, Y.,Tang, J.,Shen, J.,Kobayashi, S.(2009).Hepatoprotective effects of Coptidis rhizoma aqueous extract on carbon tetrachloride- induced acute liver hepatotoxicity in rats..J. Ethnopharmacol,124,130-136.
37. Yuan, C.,Du, L.,Jin, Z.,Xu, X.(2008).Preparation and stability of the inclusion complex of astaxanthin with hydroxypropyl-bcyclodextrin.Food Chem,109,264-268.
38. Zardi, E.M.,Abbate, A.,Zardi, D.M.,Dobrina, A.,Margiotta, D.,Van Tassel, B.W.,Afeltra, A.,Sanyal, A.J.(2010).Cirrhotic cardiomyopathy..J. Am. Coll. Cardiol.,56,539-549.
39. Zhang, C.,Guo, L.,Zhu, B.,Feng, Y.,Yu, S.,An, N.,Wang, X.(2013).Effects of 3, 5, 3'-triiodothyronine (T3) and follicle stimulating hormone on apoptosis and proliferation of rat ovarian granulosa cells..Chinese J. Physiol,56,298-305.